Home > Healthcare > Analytical Instruments > Molecular Analysis > Next Generation Sequencing Market

Next Generation Sequencing Market Share

Report ID: GMI3247
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Next Generation Sequencing Market Share

10X Genomics
BGI
Agilent Technologies Inc
Bio-Rad Laboratories
GenapSys Inc
F Hoffmann-La Roche
Illumina Inc
Oxford Nanopore Technologies
NanoString Technologies
Pacific Biosciences of California, Inc
Qiagen
PerkinElmer Inc
Thermo Fisher Scientific

are some top participants profiled in the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for next generation sequencing was valued at USD 8 billion in 2022 and is primed to progress at over 19% CAGR between 2023 and 2032 propelled by rapid advancements in next-generation sequencing in developed nations.

The exome sequencing segment is poised to be worth more than USD 20 billion in revenue by the end of 2032 as a result of its benefits including the complete coverage of coding regions and the capability to detect changes across a wide range of applications.

The academic institutes & research centers segment is anticipated to reach a valuation of USD 12 billion by 2032 owing to extensive experiments carried out in laboratories to create breakthrough next-generation sequencing treatments.

North America next generation sequencing (NGS) market is slated to reach over USD 21 billion in revenue by 2032 driven by rising incidences of genetic and cancer disorders in the region.